Fosinopril sodium
SIGMA/F1308 - ≥98% (HPLC), powder
Synonym: (2S,4S)
CAS Number: 88889-14-9
Empirical Formula (Hill Notation): C30H45NO7P · Na
Molecular Weight: 585.64
MDL Number: MFCD23704184
Linear Formula: C30H45NO7P · Na
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to off-white |
| form | powder |
| InChI | 1S/C30H46NO7P.Na/c1-4-28( |
| InChI key | TVTJZMHAIQQZTL-TXDYNIFHSA |
| originator | Bristol-Myers Squibb |
| Quality Level | 100 ![]() |
| SMILES string | O=C([O-])[C@H]1N(C(CP(CCC |
| solubility | H2O: >20 mg/mL |
| storage condition | desiccated |
| storage temp. | −20°C |
| Biochem/physiol Actions: | Fosinopril is an angiotensin converting enzyme (ACE) inhibitor. |
| Biochem/physiol Actions: | Fosinopril is an angiotensin converting enzyme (ACE) inhibitor. Fosinopril is also known to inhibit the activity of the peptide transporter PEPT2. |
| Features and Benefits: | This compound is a featured product for ADME Tox research. Click here to discover more featured ADME Tox products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm . |
| Features and Benefits: | This compound was developed by Bristol-Myers Squibb . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| General description: | Fosinopril lowers blood pressure and functions as an antihypertensive agent. It is an ester prodrug. Fosinopril is metabolised by the liver and excreted from the body by liver and kidney. It is used to treat heart failure. |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol | ![]() GHS07,GHS08 |
| Signal word | Warning |
| Hazard statements | H319 - H361d |
| Precautionary statements | P202 - P264 - P280 - P305 + P351 + P338 - P308 + P313 - P337 + P313 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |



